$MDXG News

MiMedx-Sanara Merger Faces Fresh Regulatory Obstacle – SMTI Stock Falls Below This Key Support Level For The First Time In 4 Months

MiMedx, Sanara Receive U.S. Federal Trading Commission Second Request For Additional Information, Documentary Materials For Proposed Business Combination

MIMEDX to Host Third Quarter 2026 Operating and Financial Results Conference Call on October 28, 2026

MIMEDX Announces Favorable Federal Court Ruling in AXIOFILL® Regulatory Classification Matter

MiMedx Group Announces U.S. Court Issues Favorable Ruling In Co.'s Litigation Against FDA's Regulatory Classification Of AXIOFILL

MIMEDX to Participate in Upcoming Investor Conferences

Craig-Hallum Maintains Buy on MiMedx Group, Raises Price Target to $8

Cantor Fitzgerald Reiterates Overweight on MiMedx Group, Maintains $8 Price Target

MiMedx Group, Inc. Q2 2026 Earnings Call Summary

MiMedx Group Inc (MDXG) (Q2 2026) Earnings Call Highlights: Surgical Growth and Transformative ...

MiMedx Group, Inc. (MDXG) Q2 2026 Earnings Call Transcript

MiMedx Group Q2 Earnings Call Highlights

MIMEDX Group (NASDAQ:MDXG) Shares Fall After Q2 Revenue and EPS Slightly Miss Estimates

MIMEDX Announces Second Quarter 2026 Operating & Financial Results

MIMEDX to Acquire Sanara MedTech

MiMedx Group Affirms FY2026 Sales Guidance of $260.000M-$290.000M vs $269.440M Est

MiMedx Group Q2 Adj. EPS $(0.05), Inline, Sales $64.362M Beat $63.460M Estimate

MIMEDX to Host Second Quarter 2026 Operating and Financial Results Conference Call on July 29

MiMedx Group (MDXG) Stock Faces Mixed Analyst Target Changes After Guidance Cut

How The MiMedx Group (MDXG) Story Is Shifting As Analysts Rework Price Targets